with Cdc25A in vitro. Purified GFP-ARD1A alone (lane 1) or with FLAG-Cdc25A (lane 2) was incubated with anti-FLAG M2 beads. After immunoprecipitation, the supernatants of the reactions were analyzed for GFP-ARD1A immunodepletion by SDS-PAGE (10%) and Western blotting using anti-GFP antibody. (B) ARD1 and Cdc25A associate in a co-transfection experiment. Cells were co-transfected with GFP-Cdc25A and either FLAG vector (lane1) or FLAG-ARD1A (lane 2). After immunoprecipitation with anti-FLAG-M2 beads, the immunoprecipitates were analyzed using anti-GFP antibody, followed by chemiluminescent detection. does not prevent the total decrease of Cdc25A expression induced by ARD1A/B siRNA. Cells were left untreated (lanes 1 and 2) or were treated with 10 µM MG132 for 24 hours (lanes 3 and 4) either with (lanes 2 and 4) or without (lanes 1 and 3) ARD1A/B siRNA. The level of Cdc25A in each case was assessed by Western blot. (B) ARD1 overexpression increases the abundance of Cdc25A. Cells were transfected with either GFP (upper panels) or GFP-ARD1A (lower panels) and Cdc25A was detected by immunocytochemistry. Nuclei were stained with DAPI (blue). Co-localization is indicated in the yellow in the merged views.
